424
CHARACTERIZATION OF MULTIPLE MYELOMA PATIENTS THROUGH FLOW CYTOMETRY AND CYTOGENETIC STUDIES 2013 – 2018
Lido
2195
Vezesque se leu este artigo
1089
Total PDF
1106
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 18 | 6 | 24 |
| 2025 5 | 48 | 14 | 62 |
| 2025 4 | 41 | 17 | 58 |
| 2025 3 | 62 | 10 | 72 |
| 2025 2 | 37 | 36 | 73 |
| 2025 1 | 31 | 21 | 52 |
| 2024 12 | 14 | 15 | 29 |
| 2024 11 | 33 | 15 | 48 |
| 2024 10 | 23 | 15 | 38 |
| 2024 9 | 25 | 20 | 45 |
| 2024 8 | 27 | 23 | 50 |
| 2024 7 | 19 | 15 | 34 |
| 2024 6 | 19 | 17 | 36 |
| 2024 5 | 23 | 28 | 51 |
| 2024 4 | 23 | 18 | 41 |
| 2024 3 | 20 | 18 | 38 |
| 2024 2 | 17 | 26 | 43 |
| 2024 1 | 17 | 21 | 38 |
| 2023 12 | 15 | 14 | 29 |
| 2023 11 | 28 | 28 | 56 |
| 2023 10 | 13 | 24 | 37 |
| 2023 9 | 21 | 28 | 49 |
| 2023 8 | 8 | 8 | 16 |
| 2023 7 | 15 | 9 | 24 |
| 2023 6 | 19 | 15 | 34 |
| 2023 5 | 22 | 11 | 33 |
| 2023 4 | 14 | 6 | 20 |
| 2023 3 | 19 | 22 | 41 |
| 2023 2 | 11 | 13 | 24 |
| 2023 1 | 14 | 6 | 20 |
| 2022 12 | 12 | 16 | 28 |
| 2022 11 | 17 | 15 | 32 |
| 2022 10 | 17 | 16 | 33 |
| 2022 9 | 13 | 19 | 32 |
| 2022 8 | 14 | 17 | 31 |
| 2022 7 | 13 | 26 | 39 |
| 2022 6 | 11 | 21 | 32 |
| 2022 5 | 9 | 25 | 34 |
| 2022 4 | 10 | 18 | 28 |
| 2022 3 | 12 | 25 | 37 |
| 2022 2 | 8 | 16 | 24 |
| 2021 1 | 11 | 19 | 30 |
| 2021 12 | 11 | 17 | 28 |
| 2021 11 | 14 | 21 | 35 |
| 2021 10 | 15 | 37 | 52 |
| 2021 9 | 18 | 26 | 44 |
| 2021 8 | 13 | 23 | 36 |
| 2021 7 | 20 | 34 | 54 |
| 2021 6 | 20 | 22 | 42 |
| 2021 5 | 13 | 31 | 44 |
| 2021 4 | 42 | 38 | 80 |
| 2021 3 | 16 | 21 | 37 |
| 2021 2 | 39 | 33 | 72 |
| 2020 1 | 12 | 13 | 25 |
| 2020 12 | 12 | 7 | 19 |
| 2020 11 | 18 | 14 | 32 |
Mostrar tudo
